Ranzolin-500 ER Tablet

Ranolazine 500 mg Extended Release Tablets — Anti-Anginal

Ranzolin-500 ER Tablet — Ranolazine 500 mg (Extended Release) from Trumac Healthcare PCD Pharma Franchise India

Composition Ranolazine 500 mg (Extended Release)
Dosage Form Extended Release Tablet
Pack Type Alu-Alu Blister
Pack Size 10 x 10 Tablets
MRP ₹ 1490
Therapy Cardiology — Late Sodium Current Inhibitor
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Ranzolin-500 ER Tablet

Ranzolin-500 ER Tablet contains Ranolazine 500 mg ER — for chronic stable angina unresponsive to or as adjunct to beta-blockers, calcium channel blockers, and nitrates. Provides anti-anginal effect without lowering heart rate or BP — useful in patients with hypotension or bradycardia.

Manufactured by Trumac Healthcare under WHO-GMP. Available for monopoly-based PCD pharma franchise and third-party manufacturing.

Indications

  • Chronic stable angina pectoris
  • Angina in patients intolerant of beta-blockers
  • Refractory angina (adjunct therapy)

Mechanism of Action

Ranolazine is a piperazine derivative that inhibits late sodium current in cardiac muscle — reducing sodium-induced calcium overload, improving diastolic function and reducing myocardial oxygen demand. Used for chronic stable angina unresponsive to other anti-anginals.

Dosage & Administration

Adults: 500 mg twice daily, may increase to 1000 mg twice daily.

Side Effects

Dizziness, constipation, headache, nausea, QT prolongation (monitor in cardiac patients).

Contraindications & Precautions

Severe hepatic impairment, on strong CYP3A4 inhibitors (ketoconazole, clarithromycin), prolonged QT, on QT-prolonging drugs.

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Ranzolin-500 ER Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Ranzolin-500 ER Tablet used for?

Ranzolin-500 ER Tablet contains Ranolazine 500 mg (Extended Release). Used as per the indications described above.

How should Ranzolin-500 ER Tablet be taken?

As directed by your physician. Complete the prescribed course.

Is Ranzolin-500 ER Tablet available for PCD pharma franchise?

Yes, Trumac Healthcare offers Ranzolin-500 ER Tablet on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Ranzolin-500 ER Tablet be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Ranzolin-500 ER Tablet WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.